Get Premium to unlock powerful stock data
NYSE:NVS (Switzerland)  
Novartis AG logo

Novartis AG

$ 85.17 +0.335 (+0.39%) 10:05 AM EST
P/E:
8.19
P/B:
3.13
Market Cap:
$ 186.01B
Enterprise V:
$ 197.99B
Volume:
279.76K
Avg Vol (2M):
2.47M
Also Trade In:
Volume:
279.76K
Market Cap $:
186.01B
PE Ratio:
8.19
Avg Vol (2-Month):
2.47M
Enterprise Value $:
197.99B
PB Ratio:
3.13
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.

Financials (Next Earnings Date:2022-07-19)

NVS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:NVS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 52,997
EPS (TTM) ($) 10.73
Beta 0.53
Volatility % 17.4
14-Day RSI 48.01
14-Day ATR ($) 1.52238
20-Day SMA ($) 85.778
12-1 Month Momentum % -0.57
52-Week Range ($) 79.09 - 95.17
Shares Outstanding (Mil) 2,212.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novartis AG Filings

Document Form Filing Date
No Filing Data

Headlines

See More